1. Home
  2. FSLR vs WAT Comparison

FSLR vs WAT Comparison

Compare FSLR & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Solar Inc.

FSLR

First Solar Inc.

HOLD

Current Price

$198.12

Market Cap

25.6B

Sector

Technology

ML Signal

HOLD

Logo Waters Corporation

WAT

Waters Corporation

HOLD

Current Price

$296.99

Market Cap

29.2B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSLR
WAT
Founded
1999
1958
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Laboratory Analytical Instruments
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
25.6B
29.2B
IPO Year
2006
1996

Fundamental Metrics

Financial Performance
Metric
FSLR
WAT
Price
$198.12
$296.99
Analyst Decision
Buy
Buy
Analyst Count
27
17
Target Price
$241.42
$386.38
AVG Volume (30 Days)
2.1M
1.1M
Earning Date
06-01-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
18.22
0.47
EPS
14.21
10.76
Revenue
$5,219,376,000.00
$3,165,286,000.00
Revenue This Year
$4.13
$104.66
Revenue Next Year
$15.23
$10.53
P/E Ratio
$14.10
$27.60
Revenue Growth
24.09
6.99
52 Week Low
$116.56
$275.05
52 Week High
$285.99
$414.15

Technical Indicators

Market Signals
Indicator
FSLR
WAT
Relative Strength Index (RSI) 40.35 35.98
Support Level $196.80 $281.33
Resistance Level $250.73 $308.14
Average True Range (ATR) 6.16 8.74
MACD 1.13 0.64
Stochastic Oscillator 70.13 34.70

Price Performance

Historical Comparison
FSLR
WAT

About FSLR First Solar Inc.

First Solar designs and manufactures solar photovoltaic panels, modules, and systems for use in utility-scale development projects. The company's solar modules use cadmium telluride to convert sunlight into electricity. This is commonly called thin-film technology. First Solar is the world's largest thin-film solar module manufacturer. It has production lines in Vietnam, Malaysia, the United States, and India.

About WAT Waters Corporation

Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.

Share on Social Networks: